Feedback Share Discussion Threads

[lr2] 13/5/2021 14:31

Twice as much buying as selling now.

Must be the CE mark. :)

[yump] 13/5/2021 14:06

The CE mark is not a product benefit, the clinical grade imaging is.

Selling on the CE mark is therefore amateur selling.

Anyone with sales training will know that.

The CE mark is a potential objection that can be overcome, IF the product benefits are saleable. Or a competitive advantage against another product with similar functional benefits.

1980 is when I learnt that and its worked forever.

[lr2] 13/5/2021 13:56

Who knows? We are dropping day by day on SMALL volumes. If MM's are prepared to take 2 million then they are either doing so to balance their books or they have a big buyer in the wings would be my best guesses. Alternatively, they're just messing with us.

[davwal] 13/5/2021 13:41

What does that suggest..? No signs of an actual shortage via the share price

[lr2] 13/5/2021 10:10

Current on line limits:
Sell 2mil @ 1.115p
Buy 300k @ 1.139p

[davwal] 12/5/2021 16:21

Thanks Ged5, from Costa Norfolk...

[lr2] 12/5/2021 16:11

There are other security certified apps but I've never found another that is CE certified.

Also never found an app with 'clinical grade' imaging. Think that remains Bleepa's unique selling point.

[digger2779] 12/5/2021 16:05

I'm on the playa and will look in later.Sun bouncing off my phone screen

[ged5] 12/5/2021 16:04

There was a lot of content given both in the discussion and the Q&A section.

The questions seemed to be from the medical profession but were comfortably answered.

There were one or two disappointments for me but I want to listen to the recording before I say too much.

One of the questions challenged Tom's assertion that Bleepa was the only application that was certified. The question came in late so wasn't answered. Apparently all questions will have a written response so the answer may well be interesting for us investors.

[davwal] 12/5/2021 15:52

Limited access at the mo, was anything noteworthy in the webinar?

[lr2] 12/5/2021 14:56

Keep watching this space!

[lr2] 12/5/2021 14:46

Afraid not, it slipped my mind.

[ged5] 12/5/2021 14:40

Did anyone else join the webinar today?

[ragnarr] 12/5/2021 14:30

No to stop whinging, no to buy more or both ;-)

[monkey puzzle] 12/5/2021 13:15

whinge whinge.....stop moaning and buy more

[yump] 12/5/2021 13:14

If it wasn't so serious it would be funny.

Its 2021 and a government has only just started to lay foundations for more integrated care.

FFS.

That's like Cadburys deciding that they had better secure some cocoa bean supplies as well as building a chocolate manufacturing facility.

[ragnarr] 12/5/2021 13:03

Queen's speech: Government to 'lay foundations' for more integrated carehttps://www.digitalhealth.net/2021/05/queens-speech-government-to-lay-foundations-for-more-integrated-care/(sorry LR2 if you cant use the link - its not personal)

[ged5] 12/5/2021 11:40

Well lets hear what they have to say in 20 minutes.

[lr2] 12/5/2021 10:56

Medical staff exhaustion from dealing with a pandemic is one reason why Bleepa wasn't immediately picked up and the need to have existing contracts come close to an end before taking on a different product is another. A third reason is hospital financial year ends all appear to finish on last day of March and the pandemic burnt through the previous year's finances.

It is likely that only now, in the last 6 weeks, have sales teams got a foot in the door of hospital trusts. News on sales should start appearing shortly.

[digger2779] 12/5/2021 10:43

Davy and LR2. Thanks for the heads up. It looks the biz so why isn't it selling?

[monkey puzzle] 12/5/2021 10:35

Been in a rising channel for months, this should be the bottom if support comes in?

[lr2] 12/5/2021 10:23

Thanks Davy. Links for those who want them.

[lr2] 12/5/2021 10:20

Current on line limits are:
Buy 175k at 1.1497p (small amounts 1.145p)
Sell 1.375mil at 1.11p (small amounts same price)

Didn't expect that.

[davydoo] 12/5/2021 10:11

New Bleepa demo out if you fancy something besides watching a falling price graph